Insider · CIK 0002022449
Christian Rommel
Files at CRSP (CRISPR Therapeutics AG). First filing -, latest -.
Christian Rommel files SEC Form 4 as director at CRSP (CRISPR Therapeutics AG). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christian Rommel has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | CRSP CRISPR Therapeutics AG | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 9, 2026 |
| Jun 5, 2025 | CRSP CRISPR Therapeutics AG | AGrant or award Stock Option (Right to Buy)derivative | +13,000 | $0.00 | $0 | 13,000 | Jun 6, 2025 |
Questions about Christian Rommel
Answered from the filings on this page, as of the latest one.
Is Christian Rommel buying or selling?
Christian Rommel has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christian Rommel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christian Rommel has 0.
Where does Christian Rommel file Form 4?
Christian Rommel has filed Form 4 at CRSP (CRISPR Therapeutics AG). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.